Zentek Ltd.
NCM: ZTEKLive Quote
📈 ZcoreAI Score
Our AI model analyzes Zentek Ltd.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ZTEK Z-Score →About Zentek Ltd.
Healthcare
Medical Instruments & Supplies
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
📊 Fundamental Analysis
Zentek Ltd. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 73.1% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -56.6%, which indicates that capital utilization is currently under pressure.
At a current price of $0.55, ZTEK currently trades near the bottom of its 52-week range (3%), indicating potential value or weakness (Range: $0.50 - $1.84).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$58.80M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
0.35
52W High
$1.84
52W Low
$0.50
Avg Volume
261K
Day High
Day Low